New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Scientists from the Krembil Brain Institute and the University of Toronto have made an exciting discovery that could open new ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their findings suggest that restoring copper balance could offer new treatments for disorders ...

Study author Dr. Minyoung Lee from Yonsei University College of Medicine noted, "As the population ages, it's encouraging ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

ScienceDaily: Some Diabetes Drugs Tied To Lower Risk Of Dementia, Parkinson's Disease A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, ...

Researchers at UCLA Health have discovered a molecule that shows promise in restoring memory and cognitive function in mice ...